Table 2. Histological Data of Patients... | American Society of Hematology

Table 2.

Histological Data of Patients According to the Type of Infection

	HBV Infection^* (n = 22)	HCV Infection^* (n = 5)	HBV-HCV Infected^* (n = 23)
	HBV Infection^* (n = 22)	HCV Infection^* (n = 5)	HBV DNA⁺ HCV-RNA⁻ (n = 2)	HBV DNA⁻ HCV-RNA⁺ (n = 6)	HBV DNA⁺ HCV-RNA⁺ (n = 13)	HBV DNA⁻ HCV-RNA⁻ (n = 2)
Median HAI^† score (range)	2 (0-10)	2 (1-4)	0, 3^‡	5 (1-6)	2 (0-8)	1, 3^‡
Median fibrosis score (range)	1 (0-1)	1 (0-1)	0, 1^‡	1 (0-3)	1 (0-1)	1, 1^‡
Median steatosis score (range)	0 (0-1)	1 (0-3)	1, 1^‡	1 (0-1)	0 (0-2)	0, 0^‡

	HBV Infection^* (n = 22)	HCV Infection^* (n = 5)	HBV-HCV Infected^* (n = 23)
	HBV Infection^* (n = 22)	HCV Infection^* (n = 5)	HBV DNA⁺ HCV-RNA⁻ (n = 2)	HBV DNA⁻ HCV-RNA⁺ (n = 6)	HBV DNA⁺ HCV-RNA⁺ (n = 13)	HBV DNA⁻ HCV-RNA⁻ (n = 2)
Median HAI^† score (range)	2 (0-10)	2 (1-4)	0, 3^‡	5 (1-6)	2 (0-8)	1, 3^‡
Median fibrosis score (range)	1 (0-1)	1 (0-1)	0, 1^‡	1 (0-3)	1 (0-1)	1, 1^‡
Median steatosis score (range)	0 (0-1)	1 (0-3)	1, 1^‡	1 (0-1)	0 (0-2)	0, 0^‡

Median interval between end of chemotherapy and liver biopsy was: HBV group, 9 years (range, 4 to 17); HCV group, 13 years (range, 4 to 20); HBV-HCV group, 9 years (range, 3 to 14).

†

Histological activity index.

‡

Score of each patient.

View Large

This Feature Is Available To Subscribers Only